Mo

OTC products · Product label record

Motion Sickness drug information

MECLIZINE HCL
H E B · ORAL

Product NDC: 37808-903

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameMECLIZINE HCL
Labeler / manufacturerH E B
RouteORAL
Drug classDrug class not supplied in source label
Product NDC37808-903
Label effective date2026-08-21

Official product label reference

Motion Sickness — H E B

This page contains 14 source sections for MECLIZINE HCL, oral route. Label set 9837e9af-c542-4c0f-be33-94927d67c6a7, version 10.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

Purpose

Purpose Antiemetic
Dosage and administration — label text
Directions do not take more than directed take first dose 1/2 to 1 hour before starting activity adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor
Warnings
Warnings Do not use for children under 12 years of age unless directed by a doctor. Ask a doctor before use if you have difficulty in urination due to enlargement of the prostate gland glaucoma a breathing problem such as emphysema or chronic bronchitis Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product drowsiness may occur avoid alcoholic beverages alcohol, sedatives, and tranquilizers may increase drowsiness use caution when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Active ingredient
Active ingredient (in each tablet) Meclizine HCl 25 mg
Do not use
Do not use for children under 12 years of age unless directed by a doctor.
Ask a doctor before use
Ask a doctor before use if you have difficulty in urination due to enlargement of the prostate gland glaucoma a breathing problem such as emphysema or chronic bronchitis
Ask a doctor or pharmacist
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
While using this medicine
When using this product drowsiness may occur avoid alcoholic beverages alcohol, sedatives, and tranquilizers may increase drowsiness use caution when driving a motor vehicle or operating machinery
Pregnancy or breast feeding
If pregnant or breast-feeding, ask a health professional before use.
Child safety
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Storage and handling
Other information store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) protect from heat and humidity use by expiration date on package
Inactive ingredient
Inactive ingredients colloidal silicon dioxide, D&C yellow #10 aluminum lake, lactose monohydrate, magnesium stearate, pregelatinized starch
Questions
Questions or comments? 1-800-426-9391

Official sources and product identifiers

Substances listed: MECLIZINE HYDROCHLORIDE

RxNorm identifiers: 995666

Package NDC codes

37808-903-12

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.